Reproducibility crisis: Blame it on the antibodies
The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“These serum cTnI enrichment results illustrate the major benefits of functionalized NPs compared to current antibody-based approaches: (1) NPs are capable of reproducibly and effectively enriching cTnI (Supplementary Fig. 23) across all tested serum samples without the use of antibody, thus overcoming the intrinsic antibody-related limitations (vide supra)14,15,51–53.”
From Nanoproteomics enables proteoform-resolved analysis of low-abundance proteins in human serum (2020) · cites this paper as [14]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Thus, these NPs can serve as replacements to conventional immuno-based techniques to overcome the antibody-related limitations in cTnI immunoassays and potentially address the current reproducibility crisis caused by antibodies in general14–16,51,53.”
From Nanoproteomics enables proteoform-resolved analysis of low-abundance proteins in human serum (2020) · cites this paper as [14]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Yet a recent survey found that 70% of scientists have tried and failed to reproduce results from a published experiment.1”
From Reproducibility of Quantitative Systems Pharmacology Models: Current Challenges and Future Opportunities (2019) · cites this paper as [1]
Experimental — accuracy not yet measuredIn the citing paper
“However, antibodies possess many inherent limitations: batch-to-batch variation, high cost of production, poor chemical stability, and lack of proteoform-specific epitope recognition that collectively contribute to reproducibility issues [62–64].”
From Top-down proteomics: challenges, innovations, and applications in basic and clinical research (2020) · cites this paper as [63]
In the citing paper
“However, antibody-based platforms suffer from significant limitations including the batch-to-batch variability, high cost of the antibody production, and relatively low chemical stability14,15.”
From Nanoproteomics enables proteoform-resolved analysis of low-abundance proteins in human serum (2020) · cites this paper as [14]
2 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Raise standards for preclinical cancer research
Begley, C. G., & Ellis, L. M. (2012) · Nature · doi:10.1038/483531a · Cited by 2,979
A Genecentric Human Protein Atlas for Expression Profiles Based on Antibodies
Berglund, L., Björling, E., Oksvold, P., Fagerberg, L., Asplund, A., Al-Khalili Szigyarto, C., Persson, A., Ottosson, J., Wernérus, H., Nilsson, P., et al. (2008) · Molecular & Cellular Proteomics · doi:10.1074/mcp.r800013-mcp200 · Cited by 672
Reproducibility: Standardize antibodies used in research
Bradbury, A., & Plückthun, A. (2015) · Nature · doi:10.1038/518027a · Cited by 647
Bordeaux, J., Welsh, A. W., Agarwal, S., Killiam, E., Baquero, M. T., Hanna, J. A., Anagnostou, V. K., & Rimm, D. L. (2010) · BioTechniques · doi:10.2144/000113382 · Cited by 589
An assessment of histone-modification antibody quality
Egelhofer, T. A., Minoda, A., Klugman, S., Lee, K., Kolasinska-Zwierz, P., Alekseyenko, A. A., Cheung, M.-S., Day, D. S., Gadel, S., Gorchakov, A. A., et al. (2011) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.1972 · Cited by 428
How reliable are G-protein-coupled receptor antibodies?
Michel, M. C., Wieland, T., & Tsujimoto, G. (2009) · Naunyn-Schmiedeberg's Archives of Pharmacology · doi:10.1007/s00210-009-0395-y · Cited by 306
Prassas, I., & Diamandis, E. P. (2014) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm-2013-1078 · Cited by 31
Cited by
Items 201–300 of 816
Yan, G., Wang, K., Shao, Z., Luo, L., Song, Z., Chen, J., Jin, R., Deng, X., Wang, H., Cao, Z., et al. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1713526115 · Cited by 42
“Conventional antibodies have been widely used as clinical therapeutics, including the recent breakthrough of the “cancer immunogram” (44, 45), as well as indispensable workhorses of biological experiments (46).”
BackgroundA high-throughput pipeline for validation of antibodies
Sikorski, K., Mehta, A., Inngjerdingen, M., Thakor, F. K., Kling, S., Kalina, T., Nyman, T. A., Stensland, M., Zhou, W., de Souza, G. A., et al. (2018) · Nature Methods · doi:10.1038/s41592-018-0179-8 · Cited by 40
Busby, M., Xue, C., Li, C., Farjoun, Y., Gienger, E., Yofe, I., Gladden, A. D., Epstein, C. B., Cornett, E. M., Rothbart, S. B., et al. (2016) · Epigenetics & Chromatin · doi:10.1186/s13072-016-0100-6 · Cited by 45
40 years Western blotting: A scientific birthday toast
Moritz, C. P. (2019) · Journal of Proteomics · doi:10.1016/j.jprot.2019.103575 · Cited by 42
Imaging the future: the emerging era of single‐cell spatial proteomics
Paul, I., White, C. A., Turcinovic, I., & Emili, A. (2020) · FEBS Journal · doi:10.1111/febs.15685 · Cited by 43
Locke, D., & Hoyt, C. C. (2023) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2023.1051491 · Cited by 85
“6.1.2 Clinical decision points—Antibody specificity Another challenge to standardization in IHC is the so-called “reproducibility crisis”66 in preclinical research, with antibody specificity identified as the central issue (Baker, 2015).”
BackgroundInfluentialSong, J. C., He, K., Xing, B., Pei, Y., Wang, D., Wang, Y., Li, S., Li, J., Huan, W., Zhang, Y., et al. (2022) · Analytical Chemistry · doi:10.1021/acs.analchem.2c03932 · Cited by 39
Mullane, K., & Williams, M. J. (2015) · Biochemical Pharmacology · doi:10.1016/j.bcp.2015.07.002 · Cited by 42
Aptamers as Valuable Molecular Tools in Neurosciences
Wolter, O., & Mayer, G. (2017) · Journal of Neuroscience · doi:10.1523/jneurosci.1969-16.2017 · Cited by 47
“Moreover, antibodies are associated with potential batch-to-batch variations and nonreproducible performance (Ruigrok et al., 2011; Baker, 2015).”
BackgroundAptamer-Mediated Delivery and Cell-Targeting Aptamers: Room for Improvement
Yan, A. C., & Levy, M. (2018) · Nucleic Acid Therapeutics · doi:10.1089/nat.2018.0732 · Cited by 39
“As noted above, the issue of reproducibility plagues all fields, including antibodies [24,25].”
Duan, H., Chen, X., Zhao, J., Zhu, J., Zhang, G., Fan, M., Zhang, B., Wang, X., Sun, Y., Liu, B., et al. (2021) · Journal of Clinical Microbiology · doi:10.1128/jcm.01580-21 · Cited by 39
“Despite the use of traditional antibodies, 520 including polyclonal and monoclonal antibodies, for developing ELISA (39), these 521 antibodies have high production costs and require enzyme labelling (40).”
BackgroundAncuceanu, R., Tamba, B.-I., Stoicescu, C. S., & Dinu, M. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms21010019 · Cited by 38
“On the other hand, the last decade has witnessed a growing realization of what has been dubbed “the reproducibility crisis”, ascribed to the inappropriate quality of antibodies used as reagents (115), insufficiently described methodologies or simply to the biology itself (116).”
BackgroundVIPER is a genetically encoded peptide tag for fluorescence and electron microscopy
Doh, J. K., White, J. D., Zane, H. K., Chang, Y. H., López, C. S., Enns, C. A., & Beatty, K. E. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1808626115 · Cited by 40
“Many antibodies have poor specificity and crossreactivity (11, 12), which can result in misleading observations.”
BackgroundMarking vertebrates langerhans cells, from fish to mammals
Alesci, A., Lauriano, E. R., Aragona, M., Capillo, G., & Pergolizzi, S. (2020) · Acta Histochemica · doi:10.1016/j.acthis.2020.151622 · Cited by 38
“…laboratory procedures to highlight the specificity of an antibody, the literature review highlighted several strategies to validate the use of antibodies for research applications (Baker, 2015a, b; Bradbury and Plückthun, 2015; Couchman, 2009; Edfors et al., 2018; Uhlen et al., 2016;).”
A resource of high-quality and versatile nanobodies for drug delivery
Shen, Z., Xiang, Y., Vergara, S. V., Chen, A., Xiao, Z., Santiago, U., Jin, C., Sang, Z., Luo, J., Chen, K., et al. (2021) · iScience · doi:10.1016/j.isci.2021.103014 · Cited by 43
“However, high-quality mAbs are often difficult to obtain and may have large batch-to-batch variations (Baker, 2015; Sakamoto et al., 2018; Weller, 2016).”
BackgroundHandoko, L., Kaczkowski, B., Hon, C.-C., Lizio, M., Wakamori, M., Matsuda, T., Ito, T., Jeyamohan, P., Sato, Y., Sakamoto, K., et al. (2018) · Epigenetics · doi:10.1080/15592294.2018.1469891 · Cited by 40
“Antibody quality in terms of target specificity and reproducibility is one of the emerging issues in the biological sciences [36,37].”
BackgroundYoung, A. P., & Denovan‐Wright, E. M. (2022) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2022.06.011 · Cited by 38
Label-Free Detection of Microvesicles and Proteins by the Bundling of Gliding Microtubules
Chaudhuri, S., Korten, T., Korten, S., Milani, G., Lana, T., Kronnie, G. T., & Diez, S. (2017) · Nano Letters · doi:10.1021/acs.nanolett.7b03619 · Cited by 37
Jokhio, S., Peng, I., & Peng, C. (2024) · PROTOPLASMA · doi:10.1007/s00709-024-01954-x · Cited by 41
“It should be noted that there was an unexpected band around 35 kDa for ALIX (the right one should be ~ 95 kDa).”
InfluentialIntact Transition Epitope Mapping (ITEM)
Yefremova, Y., Opuni, K. F. M., Danquah, B. D., Thiesen, H., & Glocker, M. O. (2017) · Journal of the American Society for Mass Spectrometry · doi:10.1007/s13361-017-1654-7 · Cited by 38
“Obviously, reliance on the functionality of an antibody either as a therapeutic agent or as a bioanalytical reagent is huge and the pitfalls that one might step into when an antibody’s functionality has not been understood in detail have been extensively discussed in high impact journals [5, 10, 11].”
BackgroundLaspas, P., Zhutdieva, M. B., Brochhausen, C., Musayeva, A., Zadeh, J. K., Pfeiffer, N., Xia, N., Li, H., Wess, J., & Gericke, A. (2019) · Scientific Reports · doi:10.1038/s41598-019-41425-5 · Cited by 38
New Views of Old Proteins: Clarifying the Enigmatic Proteome
Burnum-Johnson, K. E., Conrads, T. P., Drake, R. R., Herr, A. E., Iyengar, R., Kelly, R. T., Lundberg, E., MacCoss, M. J., Naba, A., Nolan, G. P., et al. (2022) · Molecular & Cellular Proteomics · doi:10.1016/j.mcpro.2022.100254 · Cited by 36
“(57, 58) The utility in biological and biomedical research of affinity reagents for characterizing and quantifying proteins and peptides is central; however, it also should elevate the challenge in validating and reproducing many of the antibodybased assays published each year.”
BackgroundWang, L., Lin, H., Zhang, J., & Wang, J. (2022) · Talanta · doi:10.1016/j.talanta.2022.123627 · Cited by 36
Anticancer or carcinogenic? The role of estrogen receptor β in breast cancer progression
Shen, K., Yu, H., Xie, B., Meng, Q., Dong, C., Shen, K., & Zhou, H. (2023) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2023.108350 · Cited by 37
Lin, Z., Wei, L., Cai, W., Zhu, Y., Tucholski, T., Mitchell, S. D., Guo, W., Ford, S. P., Diffee, G. M., & Ge, Y. (2019) · Molecular & Cellular Proteomics · doi:10.1074/mcp.tir118.001086 · Cited by 35
A consensus platform for antibody characterization
Ayoubi, R., Ryan, J., Bolívar, S. G., Alende, C., Moleón, V. R., Fotouhi, M., Alqazzaz, M., Southern, K., Alshafie, W., Baker, M. R., et al. (2024) · Nature Protocols · doi:10.1038/s41596-024-01095-8 · Cited by 73
Self-citationPan, Y., Sackmann, E. K., Wypisniak, K., Hornsby, M. J., Datwani, S. S., & Herr, A. E. (2016) · Scientific Reports · doi:10.1038/srep39774 · Cited by 35
Dirnagl, U., Kurreck, C., Castaños‐Vélez, E., & Bernard, R. (2018) · The EMBO Reports · doi:10.15252/embr.201847143 · Cited by 35
“There is strong evidence that weaknesses in planning, conducting, analyzing, and (non)reporting of research [2], as well as misidentification or contamination of reagents, biologicals, and cell lines [3], are prevalent factors.”
Ren, X., Wang, H.-Y., Li, S., He, X., Li, W., & Zhang, Y. (2020) · Talanta · doi:10.1016/j.talanta.2020.121706 · Cited by 35
Monoclonal Anti-AMP Antibodies Are Sensitive and Valuable Tools for Detecting Patterns of AMPylation
Höpfner, D., Fauser, J., Kaspers, M. S., Pett, C., Hedberg, C., & Itzen, A. (2020) · iScience · doi:10.1016/j.isci.2020.101800 · Cited by 35
“The reproducibility crisis of antibodies in recent years (Baker, 2015), as well as the limitations of commercially available anti-AMPylation-antibodies (Hao et al., 2011) (Sigma-Aldrich ABS184 and 09-890) let us to perform a thorough evaluation of the new monoclonal antibodies’ performance in two…”
BackgroundMethodElevated plasma complement factor H related 5 protein is associated with venous thromboembolism
Iglesias, M. J., Sánchez‐Rivera, L., Ibrahim‐Kosta, M., Naudin, C., Munsch, G., Goumidi, L., Farm, M., Smith, P. M., Thibord, F., Kral-Pointner, J. B., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-38383-y · Cited by 42
“…quality control for antigen binding speci fi city (see www.proteinatlas.org/), but selective binding to the target protein in context of the complex matrix of plasma requires veri fi cation, as antibody speci fi city and reliability can be a problematic issue 30 – 32 (Supplementary information Fig.”
Freedman, L. P., Gibson, M. C., Bradbury, A. R. M., Buchberg, A. M., Davis, D., Dolled-Filhart, M. P., Lund-Johansen, F., & Rimm, D. L. (2016) · BioTechniques · doi:10.2144/000114431 · Cited by 34
Helzer, K. T., Ozers, M. S., Meyer, M. B., Benkusky, N. A., Solodin, N. M., Reese, R., Warren, C. L., Pike, J. W., & Alarid, E. T. (2018) · Molecular and Cellular Biology · doi:10.1128/mcb.00417-18 · Cited by 36
“Given the issues with antibody reliability, particularly for posttranslational modifications (48, 49), we conducted separate ChIP-seq experiments with three pS118-ER antibodies to yield a high-confidence pS118-ER data set.”
MethodMultiplex Viral Detection Platform Based on a Aptamers-Integrated Microfluidic Channel
Saraf, N., Villegas, M., Willenberg, B. J., & Seal, S. (2019) · ACS Omega · doi:10.1021/acsomega.8b03277 · Cited by 34
Alnajrani, M. N., & Alsager, O. A. (2019) · Analytical Biochemistry · doi:10.1016/j.ab.2019.113461 · Cited by 34
Frohner, I. E., Mudrak, I., Kronlachner, S., Schüchner, S., & Ogris, E. (2020) · Science Signaling · doi:10.1126/scisignal.aax6490 · Cited by 38
Listek, M., Hönow, A., Gossen, M., & Hanack, K. (2020) · Scientific Reports · doi:10.1038/s41598-020-58571-w · Cited by 34
Choi, D., Ryu, S., & Kong, M. (2025) · Comprehensive Reviews in Food Science and Food Safety · doi:10.1111/1541-4337.70124 · Cited by 38
“Although Abs are the most frequently used detection agents, in many cases, they present a significant bottle-neck, known as the “reproducibility crisis” (Baker, 2015).”
Monitoring Intact Viruses Using Aptamers
Kumar, P. K. R. (2016) · Biosensors · doi:10.3390/bios6030040 · Cited by 33
Dispersive solid-phase imprinting of proteins for the production of plastic antibodies
Ashley, J. A., Feng, X., Halder, A., Zhou, T., & Sun, Y. (2018) · Chemical Communications · doi:10.1039/c8cc00343b · Cited by 33
Antibody characterization is critical to enhance reproducibility in biomedical research
Kahn, R. A., Virk, H., Laflamme, C., Houston, D. W., Polinski, N. K., Meijers, R., Levey, A. I., Saper, C. B., Errington, T. M., Turn, R. E., et al. (2024) · eLife · doi:10.7554/elife.100211 · Cited by 32
“…that ~50% of commercial antibodies fail to meet even basic standards for characterization, and this problem is thought to result in financial losses of $0.4–1.8 billion per year in the United States alone ( Ayoubi et al., 2023 ; Bradbury and Plückthun, 2015 ; Voskuil et al., 2020 ; Baker, 2015b ).”
BackgroundInfluentialSun, B., Li, G., Wu, Y. H., Gai, J., Zhu, M., Ji, W., Wang, X., Zhang, F., Li, W., Hu, J., et al. (2024) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.4c14027 · Cited by 33
Wang, Y., He, Y. Q., Bhattacharyya, S., Lu, S., & Fu, Z. (2020) · Analytical Chemistry · doi:10.1021/acs.analchem.9b05295 · Cited by 32
Extracellular Vesicles and Preeclampsia: Current Knowledge and Future Research Directions
Palma, C., Jellins, J., Lai, A., Salas-Burgos, A., Campos, A. V., Sharma, S., Duncombe, G. J., Hyett, J. A., & Salomón, C. (2021) · Sub-cellular biochemistry/Subcellular biochemistry · doi:10.1007/978-3-030-67171-6_18 · Cited by 37
Kumar, M., Joseph, S. R., Augsburg, M., Bogdanova, A. I., Drechsel, D. N., Vastenhouw, N. L., Buchholz, F., Gentzel, M., & Shevchenko, A. (2017) · Molecular & Cellular Proteomics · doi:10.1074/mcp.o117.067082 · Cited by 32
“Despite well-known technical limitations and numerous application pitfalls, Western blotting (WB) remains one of the most widely used tools in analytical biochemistry (reviewed in (1-7)).”
MethodMolecular chaperones and G protein-coupled receptor maturation and pharmacology
Tao, Y. (2020) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2020.110862 · Cited by 33
Niehues, H., van Vlijmen‐Willems, I. M. J. J., Bergboer, J. G. M., Kersten, F. F. J., Narita, M., Hendriks, W. J. A. J., van den Bogaard, E. H. J., Zeeuwen, P. L. J. M., & Schalkwijk, J. (2015) · British Journal of Dermatology · doi:10.1111/bjd.14284 · Cited by 35
Biosensor binding data and its applicability to the determination of active concentration
Karlsson, R. (2016) · Biophysical Reviews · doi:10.1007/s12551-016-0219-5 · Cited by 31
Systematic assessment of antibody selectivity in plasma based on a resource of enrichment profiles
Fredolini, C., Byström, S., Sánchez‐Rivera, L., Ioannou, M., Tamburro, D., Pontén, F., Branca, R. M., Nilsson, P., Lehtiö, J., & Schwenk, J. M. (2019) · Scientific Reports · doi:10.1038/s41598-019-43552-5 · Cited by 34
Klont, F., Pouwels, S. D., Hermans, J. H., van de Merbel, N. C., Horvatovich, P. L., ten Hacken, N. H. T., & Bischoff, R. (2018) · Talanta · doi:10.1016/j.talanta.2018.02.015 · Cited by 30
“The former approach is a widely-used application of antibodies in basic and applied scienti fi c research, and has contributed to the conception of antibodies being the ‘ workhorses ’ of (bio)medical experiments [6].”
Atlasi, R. S., Malik, R., Corrales, C. I., Tzeplaeff, L., Whitelegge, J. P., Cashman, N. R., & Bitan, G. (2018) · ACS Chemical Biology · doi:10.1021/acschembio.8b00729 · Cited by 30
Publications, replication and statistics in physiology plus two neglected curves
Gandevia, S. C. (2021) · The Journal of Physiology · doi:10.1113/jp281360 · Cited by 30
“Why was this needed? In part it stemmed from a realisation that many if not a majority of research findings are likely to be false (Ioannidis, 2005), and thus many publications were inevitably contributing to what some call a crisis in reproducibility (Baker, 2015) (cf.”
BackgroundWang, F., Zahid, O. K., Swain, B. E., Parsonage, D., Hollis, T., Harvey, S. E., Perrino, F. W., Kohli, R. M., Taylor, E. W., & Hall, A. R. (2017) · Nano Letters · doi:10.1021/acs.nanolett.7b03911 · Cited by 32
Multichannel Open Tubular Enzyme Reactor Online Coupled with Mass Spectrometry for Detecting Ricin
Brandtzaeg, O. K., Røen, B. T., Enger, S., Lundanes, E., & Wilson, S. R. (2017) · Analytical Chemistry · doi:10.1021/acs.analchem.7b02590 · Cited by 29
Dang, Z., Shangguan, J.-Y., Zhang, C., Hu, P., Ren, Y., Lv, Z., Xiang, H., & Wang, X. (2015) · Tumor Biology · doi:10.1007/s13277-015-3970-5 · Cited by 29
Gong, B., Murray, K. D., & Trimmer, J. S. (2015) · New Biotechnology · doi:10.1016/j.nbt.2015.11.007 · Cited by 31
“com/locate/nbt model may not be directly relevant to large-scale efforts to address what many end users feel is a rising tide of substandard Ab-based data across broad areas of biomedical research [4].”
BackgroundInfluentialHedberg‐Buenz, A., Christopher, M. A., van der Heide, C. J., Fernandes, K. A., Dutca, L. M., Wang, K., Scheetz, T. E., Abràmoff, M. D., Libby, R. T., Garvin, M. K., et al. (2015) · Experimental Eye Research · doi:10.1016/j.exer.2015.09.011 · Cited by 33
“…these depend on the specificity of the antibody with respect to retinal cell type, RGC sub-type, disease state, and (too often) the precise manufacturer and lot of the antibody, all of which can confound analyses (Soto, Oglesby et al. 2008, Rodriguez, de Sevilla Muller et al. 2014, Baker 2015).”
BackgroundThe Application of Aptamers for Immunohistochemistry
Bauer, M., MacDonald, J. P., Henri, J., Duan, W., & Shigdar, S. L. (2016) · Nucleic Acid Therapeutics · doi:10.1089/nat.2015.0569 · Cited by 30
“There are currently more than 2 million commercially available antibodies, marketed by over 300 different companies [13].”
Systems Biology Analysis of Heterocellular Signaling
Tape, C. J. (2016) · Trends in biotechnology · doi:10.1016/j.tibtech.2016.02.016 · Cited by 30
“Antibodies suffer from poor specificity, batch-to-batch variation, limited reporter channels and can measure only those events for which there is a high-performing reagent [39].”
BackgroundMurtaza, G., Mermer, P., Goldenberg, A., Pfeil, U., Paddenberg, R., Weißmann, N., Lochnit, G., & Kummer, W. (2017) · PLoS ONE · doi:10.1371/journal.pone.0174071 · Cited by 29
Isolation of isoform-specific binding proteins (Affimers) by phage display using negative selection
Tang, A. A.-S., Tiede, C., Hughes, D. J., McPherson, M. J., & Tomlinson, D. C. (2017) · Science Signaling · doi:10.1126/scisignal.aan0868 · Cited by 34
“However, there is a widespread lack of reproducibility and selectivity of antibodies and a growing drive to use methods that directly yield recombinant binding reagents that can be sequenced and easily produced in a reproducible manner (1, 2).”
BackgroundBlackwell, L. F., Cooke, D. G., & Brown, S. B. (2018) · Frontiers in Public Health · doi:10.3389/fpubh.2018.00153 · Cited by 37
“The antibody used in the assays matters and always should be thoroughly characterized (70).”
BackgroundPeck Justice, S. A., Barron, M. P., Qi, G. D., Wijeratne, H. R. S., Victorino, J. F., Simpson, E. R., Vilseck, J. Z., Wijeratne, A. B., & Mosley, A. L. (2020) · Journal of Biological Chemistry · doi:10.1074/jbc.ra120.014576 · Cited by 28
“Considering the inherent challenges with antibody-based methods because of specificity concerns (34), methods that avoid dependence on antibodies are likely to increase the rigor and reproducibility of mutant protein interrogation.”
MethodPeck Justice, S. A., Qi, G., Wijeratne, H. R. S., Victorino, J. F., Simpson, E. R., Wijeratne, A. B., & Mosley, A. L. (2019) · doi:10.1101/2019.12.30.891267 · Cited by 28
“, Baker, P. W., & Cripps, R. M. (2009). A molecular mechanism of temperature sensitivity for mutations affecting the Drosophila muscle regulator Myocyte enhancer factor-2. Genetics, 183(1), 107-117. doi:10.1534/genetics.109.105056 Mann, M., Kulak, N. A., Nagaraj, N., & Cox, J. (2013). The coming age of complete, accur…”
BackgroundMethodInfluentialZhou, L., Shi, L., Guo, H., & Yao, X. (2015) · Tumor Biology · doi:10.1007/s13277-015-4138-z · Cited by 28
“Despite we have tested and evaluated the primary antibody against MYSM-1 prior to experiment, which may lead to the biased and irreproducible biomedical results [16, 17], there is still limitation in our study.”
ResultResolving Sulfation Posttranslational Modifications on a Peptide Hormone using Nanopores
Chen, X., van de Sande, J. W., Ritmejeris, J., Wen, C., Brinkerhoff, H. D., Laszlo, A. H., Albada, B., & Dekker, C. (2024) · ACS Nano · doi:10.1021/acsnano.4c09872 · Cited by 31
Mass Spectrometry Imaging in Cancer Research
McDonnell, L. A., Angel, P. M., Lou, S., & Drake, R. R. (2016) · Advances in cancer research · doi:10.1016/bs.acr.2016.11.010 · Cited by 31
Schüchner, S., Behm, C., Mudrak, I., & Ogris, E. (2020) · Science Signaling · doi:10.1126/scisignal.aax9730 · Cited by 29
Sfanos, K. S., Yegnasubramanian, S., Nelson, W. G., Lotan, T. L., Kulaç, İ., Hicks, J. L., Zheng, Q., Bieberich, C. J., Haffner, M. C., & Marzo, A. M. D. (2018) · Asian journal of urology · doi:10.1016/j.ajur.2018.11.006 · Cited by 30
Klont, F., Hadderingh, M., Horvatovich, P. L., ten Hacken, N. H. T., & Bischoff, R. (2018) · Journal of Proteome Research · doi:10.1021/acs.jproteome.8b00414 · Cited by 28
p16 methylation is a potential predictive marker for abemaciclib sensitivity in gastric cancer
Bae, H. J., Kang, S. K., Kwon, W. S., Jeong, I., Park, S., Kim, T. S., Kim, K. H., Kim, H., Jeong, H.-C., Chung, H. C., et al. (2020) · Biochemical Pharmacology · doi:10.1016/j.bcp.2020.114320 · Cited by 31
Transforming nanobodies into high-precision tools for protein function analysis
Gettemans, J., & Dobbelaer, B. D. (2020) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00435.2020 · Cited by 32
“instance are available only in finite quantities and producing exactly the same batch of antibodies 110 even in the same animal is virtually impossible (8, 22).”
BackgroundMultiplexed selectivity screening of anti-GPCR antibodies
Dahl, L., Kotliar, I. B., Bendes, A., Dodig‐Crnković, T., Fromm, S., Elofsson, A., Uhlén, M., Sakmar, T. P., & Schwenk, J. M. (2023) · Science Advances · doi:10.1126/sciadv.adf9297 · Cited by 29
“However, in recent years, especially in the context of proteomics studies, the widespread or indiscriminate use of Abs without their proper independent validation has been challenged (4).”
BackgroundOmics/systems biology and cancer cachexia
Gallagher, I. J., Jacobi, C., Tardif, N., Rooyackers, O., & Fearon, K. (2016) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2015.12.022 · Cited by 30
“Recently awareness of the limitations of antibody technology in proteomics has increased [24,25].”
BackgroundDelle, L. E., Pachauri, V., Sharma, S., Shaforost, O., Ma, H., Adabi, M., Lilischkis, R., Wagner, P., Thoelen, R., Klein, N., et al. (2017) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2017.12.005 · Cited by 27
Ellis, M. J., Lekka, C., Holden, K. L., Tulmin, H., Seedat, F., O'Brien, D. P., Dhayal, S., Zeissler, M., Knudsen, J. G., Kessler, B. M., et al. (2024) · Acta Neuropathologica · doi:10.1007/s00401-024-02729-7 · Cited by 34
“Indeed, quality issues with research antibodies have been highlighted as one of the main contributors to the widely acknowledged “reproducibility crisis” in scientific research [5, 11, 25, 116, 162].”
BackgroundRadiolabelled Aptamers for Theranostic Treatment of Cancer
Khalid, U., Vi, C., Henri, J., MacDonald, J. P., Eu, P., Mandarano, G., & Shigdar, S. L. (2018) · Pharmaceuticals · doi:10.3390/ph12010002 · Cited by 29
“Antibodies Multiple targets Targeted delivery of drug Batch to batch variations, cross reactivity [127,128]”
BackgroundEnhanced Validation of Antibodies Enables the Discovery of Missing Proteins
Sivertsson, Å., Lindström, E., Oksvold, P., Katona, B., Hikmet, F., Vuu, J., Gustavsson, J., Sjöstedt, E., von Feilitzen, K., Kampf, C., et al. (2020) · Journal of Proteome Research · doi:10.1021/acs.jproteome.0c00486 · Cited by 37
“29,30 There is a widely acknowledged demand to require higher standards by antibody providers, 4 but even a speci fi c antibody may produce false-positive results due to unspeci fi c o ff -target binding if the protocol is not properly optimized, ultimately leaving the responsibility on the individual…”
Elimination of undifferentiated human embryonic stem cells by cardiac glycosides
Lin, Y.-T., Wang, C.-K., Yang, S.-C., Hsu, S.-C., Lin, H., Chang, F., Kuo, T.-C., Shen, C., Chiang, P., Hsiao, M., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-05616-2 · Cited by 26
A mini-review and perspective on multicyclic peptide mimics of antibodies
Liu, W., & Wu, C. (2018) · Chinese Chemical Letters · doi:10.1016/j.cclet.2018.03.015 · Cited by 26
Woodland, B., Farrell, L. A., Brockbals, L., Rezcallah, M. C., Brennan, A., Sunnucks, E. J., Gould, S. T., Stanczak, A. M., O’Rourke, M. B., & Padula, M. P. (2025) · PROTEOMICS · doi:10.1002/pmic.13983 · Cited by 26
Cayer, D. M., Nazor, K. L., & Schork, N. J. (2016) · Human Molecular Genetics · doi:10.1093/hmg/ddw214 · Cited by 29
“The availability of antibodies ( 2 million commercially available) (66); that could potentially identify all subtle variations in proteins make them a very attractive set of molecules to use for protein interrogation, although their use does suffer from issues like cross-reactivity, batch variability, and application…”
BackgroundGibert‐Ramos, A., López, C., Bosch, R., Fontoura, L., Bueno, G., García‐Rojo, M., Berenguer, M., & Lejeune, M. (2019) · Histochemistry and Cell Biology · doi:10.1007/s00418-019-01802-7 · Cited by 28
Whiteaker, J. R., Lundeen, R. A., Zhao, L., Schoenherr, R. M., Burian, A., Huang, D., Voytovich, U. J., Wang, T., Kennedy, J. J., Ivey, R. G., et al. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.765898 · Cited by 27
Song, M.-S., Alluin, J. V., & Rossi, J. J. (2022) · Genes · doi:10.3390/genes13030436 · Cited by 29
“It is of utmost importance to find an excellent antibody to reduce cross-reactivities with offtarget proteins that can lead to the recognized issue of experimental irreproducibility [56,57].”
BackgroundA Combination of G Protein–Coupled Receptor Modulators Protects Photoreceptors from Degeneration
Orban, T., Leinonen, H., Getter, T., Dong, Z., Sun, W., Gao, S., Veenstra, A. A., Heidari‐Torkabadi, H., Kern, T. S., Kiser, P. D., et al. (2017) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.117.245167 · Cited by 28
“localization (Baker, 2015), so a PCR approach was chosen in Fig.”
MethodPEP-on-DEP: A competitive peptide-based disposable electrochemical aptasensor for renin diagnostics
Biyani, M., Kawai, K., Kitamura, K., Chikae, M., Biyani, M., Ushijima, H., Tamiya, E., Yoneda, T., & Takamura, Y. (2015) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2015.12.078 · Cited by 25
Robak, A., Kistowski, M., Wojtas, G., Perzanowska, A., Targowski, T., Michalak, A., Krasowski, G., Dadlez, M., & Domański, D. (2022) · Scientific Reports · doi:10.1038/s41598-022-06924-y · Cited by 26
How to avoid pitfalls in antibody use
Pauly, D., & Hanack, K. (2015) · F1000Research · doi:10.12688/f1000research.6894.1 · Cited by 27
Systematic quantitative analysis of H2A and H2B variants by targeted proteomics
Kennani, S. E., Adrait, A., Permiakova, O., Hesse, A.-M., Ialy‐Radio, C., Ferro, M., Brun, V., Cocquet, J., Govin, J., & Pflieger, D. (2018) · Epigenetics & Chromatin · doi:10.1186/s13072-017-0172-y · Cited by 26
“Finally, lot-to-lot variations of antibodies can result in a lack of reproducibility [16, 17].”
Assaying epigenome functions of PRMTs and their substrates
Rakow, S., Pullamsetti, S. S., Bauer, U., & Bouchard, C. (2019) · Methods · doi:10.1016/j.ymeth.2019.09.014 · Cited by 28
Pulverer, B. (2015) · The EMBO Journal · doi:10.15252/embj.201570090 · Cited by 24
“It has been known for years that many antibodies and small molecule reagents do not — or do not only — detect what it says on the box, yet antibody validation efforts such as antibodypedia are still not routine (Bjo¨rling & Uhle´n, 2008; Baker, 2015).”
Lai, W., Mariani, L., Rothschild, G., Smith, E. R., Venters, B. J., Blanda, T. R., Kuntala, P. K., Bocklund, K., Mairose, J. D., Dweikat, S. N., et al. (2021) · Genome Research · doi:10.1101/gr.275472.121 · Cited by 27
“Antibody validation is required to generate confidence in their utility (Baker 2015; Marx 2019).”
Diffusing protein binders to intrinsically disordered proteins
Liu, C., Wu, K., Choi, H., Han, H., Zhang, X., Watson, J. L., Shijo, S., Bera, A. K., Kang, A., Brackenbrough, E., et al. (2024) · doi:10.1101/2024.07.16.603789 · Cited by 24
Recent advances in molecularly imprinted polymers for glycosylated molecule analysis
Ali, M. M., Liu, X., Amin, F. R., Zhou, J., & Hu, L. (2025) · TrAC Trends in Analytical Chemistry · doi:10.1016/j.trac.2025.118168 · Cited by 23
Marino, M. J. (2017) · Biochemical Pharmacology · doi:10.1016/j.bcp.2017.12.011 · Cited by 27
Yang, L. F., Kacherovsky, N. A., Liang, J., Salipante, S. J., & Pun, S. H. (2022) · Analytical Chemistry · doi:10.1021/acs.analchem.2c01993 · Cited by 25
Cui, Y., Wang, X., Wu, H., Zhang, X., Xu, Y., Yu, G., Liu, X., Yao, Q., Wang, J., & Ji, Y. (2024) · Food Control · doi:10.1016/j.foodcont.2024.110313 · Cited by 25
Weinzapfel, E. N., Fedder-Semmes, K. N., Sun, Z., & Keogh, M. (2024) · Biochemical Journal · doi:10.1042/bcj20230342 · Cited by 27
T‐cell receptor gene therapy — ready to go viral?
Kärpänen, T., & Olweus, J. (2015) · Molecular Oncology · doi:10.1016/j.molonc.2015.10.006 · Cited by 26
“With better systems for high-throughput antibody validation (Baker, 2015; Bradbury and Pluckthun, 2015; Holm et al., 2012), the quality of available immunohistochemistry data will gradually improve.”
Method
Metadata
- Authors
- Baker, M.
- Corresponding author
- Baker, Monya
- Venue
- Nature
- Published
- 2015-05-19
- Volume
- 521
- Issue
- 7552
- Pages
- 274-276
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W1592986776
- Cited by
- 830
- References
- 7
- Citations by year
- 2026: 55 · 2025: 58 · 2024: 56 · 2023: 57 · 2022: 67 · 2021: 68 · 2020: 78 · 2019: 75 · 2018: 87 · 2017: 93 · 2016: 83 · 2015: 51
- Type
- other
- Language
- en
- Open access
- closed
- Licence
- www.springernature.com/gp/researchers/text-and-data-mining (tdm)
- www.springernature.com/gp/researchers/text-and-data-mining (vor)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Monoclonal and Polyclonal Antibodies Research
- Health Sciences › Veterinary › Small Animals › Animal testing and alternatives
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Advanced Biosensing Techniques and Applications
- Keywords
- replication crisis, immunoglobulins, antibody validation, scientific rigor, research integrity
- MeSH terms
- Antibodies, Antibody Specificity, Cross Reactions, Humans, Indicators and Reagents, Membrane Proteins, Quality Control, Reagent Kits, Diagnostic, Reproducibility of Results, Artifacts
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.